Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer
暂无分享,去创建一个
Damiano Caruso | Marco Rengo | Andrea Laghi | Maria Ciolina | Simona Marzi | Davide Bellini | M. Caterino | M. Rengo | A. Laghi | D. Caruso | D. De Santis | D. Bellini | M. Ciolina | V. Tombolini | S. Marzi | Vincenzo Tombolini | Daniela Musio | S. Picchia | D. Musio | Simona Picchia | Mauro Caterino | Domenico De Santis
[1] Stuart A. Taylor,et al. Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting , 2018, European Radiology.
[2] R. Vera,et al. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease‐free survival after preoperative radiochemotherapy for advanced rectal cancer , 2008, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[3] L. Påhlman,et al. Is radiochemotherapy necessary in the treatment of rectal cancer? , 1998, European journal of cancer.
[4] A. O'Grady,et al. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer , 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[5] D. Aust,et al. Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer. , 2016, European journal of cancer.
[6] P. Delrio,et al. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile , 2016, Oncotarget.
[7] J. Monson,et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial , 2009, The Lancet.
[8] L. Stassen,et al. Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment , 2015, Annals of Surgical Oncology.
[9] Stuart A. Taylor,et al. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting , 2017, European Radiology.
[10] P. Delrio,et al. Standardized Index of Shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC , 2015, European Radiology.
[11] T L Chenevert,et al. Utility of the K-Means Clustering Algorithm in Differentiating Apparent Diffusion Coefficient Values of Benign and Malignant Neck Pathologies , 2010, American Journal of Neuroradiology.
[12] Ich Harmonised,et al. INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE , 2006 .
[13] Ivana Blažić,et al. MRI for evaluation of treatment response in rectal cancer. , 2016, The British journal of radiology.
[14] O. C. S. Mrcs,et al. MRI Predictive Factors for Long-Term Outcomes of Low Rectal Tumours , 2011, Annals of Surgical Oncology.
[15] P. Delrio,et al. MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report , 2015, BioMed research international.
[16] R. Perez,et al. Nonoperative management of rectal cancer: identifying the ideal patients. , 2015, Hematology/oncology clinics of North America.
[17] G. Brandi,et al. Neoadjuvant Treatment in Rectal Cancer: Actual Status , 2011, Chemotherapy research and practice.
[18] P. Tekkis,et al. Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG). , 2016, Clinical radiology.
[19] Nickolas Papanikolaou,et al. Role of Magnetic Resonance Imaging in Primary Rectal Cancer-Standard Protocol and Beyond. , 2016, Seminars in ultrasound, CT, and MR.
[20] V. Tombolini,et al. Neoadjuvant-intensified treatment for rectal cancer: time to change? , 2013, World journal of gastroenterology.
[21] Ivan Cecconello,et al. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer , 2016, Diseases of the colon and rectum.
[22] Gina Brown,et al. Magnetic Resonance Tumor Regression Grade and Residual Mucosal Abnormality as Predictors for Pathological Complete Response in Rectal Cancer Postneoadjuvant Chemoradiotherapy , 2016, Diseases of the colon and rectum.
[23] Rainer Fietkau,et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] C. Marijnen,et al. The role of radiotherapy in rectal cancer. , 2001, European journal of cancer.
[25] P. D. Peppercorn,et al. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study , 2006, BMJ : British Medical Journal.
[26] S. Andreola,et al. Pathological features of rectal cancer after preoperative radiochemotherapy , 1998, International Journal of Colorectal Disease.
[27] F. Taylor,et al. MRI after treatment of locally advanced rectal cancer: how to report tumor response--the MERCURY experience. , 2012, AJR. American journal of roentgenology.
[28] Angelita Habr-Gama,et al. Watch and Wait Approach Following Extended Neoadjuvant Chemoradiation for Distal Rectal Cancer: Are We Getting Closer to Anal Cancer Management? , 2013, Diseases of the colon and rectum.
[29] S. Ricci,et al. Comparison of Magnetic Resonance Imaging and Histopathological Response to Chemoradiotherapy in Locally Advanced Rectal Cancer , 2012, Annals of Surgical Oncology.
[30] S. Balyasnikova,et al. Imaging Advances in Colorectal Cancer , 2016, Current Colorectal Cancer Reports.
[31] M. Lahaye,et al. Accuracy of MRI in Restaging Locally Advanced Rectal Cancer After Preoperative Chemoradiation , 2017, Diseases of the colon and rectum.
[32] Rainer Fietkau,et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.
[33] Gina Brown,et al. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales , 2016, World journal of gastroenterology.
[34] Sang Woo Lim,et al. Coloproctology Clinical Significance of Tumor Regression Grade in Rectal Cancer with Preoperative Chemoradiotherapy , 2022 .